CEO Total Pay
$13.6M
FY2024 Summary Compensation, above median
BPMC FY2024 SEC EDGAR DEF 14A
Blueprint Medicines Corp CEO pay ratio
The CEO earned $13.6M in FY2024 against median worker pay of $389,871 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2025-04-24
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2024
Data updated August 2026
Subscribe to Blueprint Medicines Corp CEO pay filing updates (RSS)
CEO-to-worker pay ratio
35:1
Below Average (Scale: 0–1000:1)
CEO pay
$13.6M
Median worker
$389,871
Latest filing FY2024. This company's newest DEF 14A on file is for FY2024, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Blueprint Medicines Corp reported a 35:1 CEO-to-worker pay ratio in FY2024 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 35:1
- FY2024 disclosed
- CEO total
- $13.6M
- Summary Compensation Table total
- Median worker
- $389,871
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2024
A component-level pay breakdown is not reported in Blueprint Medicines Corp's structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
35:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$13.6M
Companies in Industry
168
vs. Industry Median
Below
Blueprint Medicines Corp: MODEST · HEAVY pay ratio
Blueprint Medicines Corp disclosed 35:1 CEO-to-worker pay and $13.6M CEO total in FY2024. the CEO earned 35× the median employee ($389,871) in FY2024.
Median employee $389,871 (ELITE-MED); MODEST · HEAVY stamps put about 35 median-wage years per CEO year.
Pay Ratio
35:1
Below typical
What FY2024 shows for Blueprint Medicines Corp
Blueprint Medicines Corp disclosed 35:1 CEO-to-worker pay and $13.6M CEO total in FY2024. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Blueprint Medicines Corp's $13.6M CEO total is above the $7.9M industry median CEO pay.
Blueprint Medicines Corp stamps MODEST · HEAVY · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2024
- Total Compensation
- $13.6M
- Median Employee Pay
- $389,871
- Pay Ratio
- 35:1
- Filing Date
- 2025-04-24
Company Info
- Ticker
- BPMC
- CIK
- 1597264
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- DE
SEC EDGAR DEF 14A for CIK 1597264, FY2024. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Blueprint Medicines Corp disclosed 35:1 CEO-to-worker pay and $13.6M CEO total in FY2024.
Read with Blueprint Medicines Corp
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.
Myriad Genetics Inc · HEAVY
ABS(ceo_total_comp) peer at $13.6M (Δ $8K lighter vs Blueprint Medicines Corp); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Ultragenyx Pharmaceutical Inc. · HEAVY
ABS(ceo_total_comp) peer at $13.7M (Δ $17K heavier vs Blueprint Medicines Corp); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Crown Holdings, Inc. · HEAVY
ABS(ceo_total_comp) peer at $13.6M (Δ $17K lighter vs Blueprint Medicines Corp); HIGH · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Bentley Systems Inc · HEAVY
ABS(ceo_total_comp) peer at $13.7M (Δ $20K heavier vs Blueprint Medicines Corp); STEEP · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Blueprint Medicines Corp stamps MODEST · HEAVY · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · MODEST
See where MODEST · HEAVY packages sit on the national leaderboard after reading Blueprint Medicines Corp.
Ratio primer · MODEST
Blueprint Medicines Corp's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Blueprint Medicines Corp (CIK 1597264), FY2024. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.